PHIA Koninklijke Philips N.V.

Philips recognized in Gartner’s 2020 Market Guide for Virtual Care Solutions

Philips recognized in Gartner’s 2020 Market Guide for Virtual Care Solutions

November 5, 2020

The ability to support the delivery of virtual care is now a must-have capability for all healthcare delivery organizations identified in report

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has been identified as a Representative Vendor in the Gartner "Market Guide for Virtual Care Solutions" report [1]. The report underscores that “virtual care solutions enable healthcare delivery organizations to provide high-quality, cost-effective clinical care at a distance.” Such solutions help seamlessly drive clinical and operational efficiencies by empowering clinicians with key patient data to enhance decision-making.

“We are pleased that Gartner has recognized Philips as a Representative Vendor for its enterprise virtual care portfolio and telehealth portfolio in their recent Market Guide,” said Roy Jakobs, Chief Business Leader Connected Care at Royal Philips. “Virtual care has empowered clinicians to meet patient needs, even during COVID-19. By strategically partnering with our customers, Philips is helping health systems build programs to address the immediate demands of the pandemic, while also building sustainable and scalable systems that will extend beyond COVID-19 to enable the right care anywhere, anytime.”

In its report, Gartner identified five critical capabilities for virtual care solutions – (a) clinician experience, (b) patient experience, (c) artificial intelligence, (d) information capture for billing and reporting, and (e) modular, open solutions. Philips was included as a Representative Vendor based on its telehealth and virtual care solutions. Moreover, Philips aims to meet healthcare providers’ needs through its platform-based virtual care approach to help deliver on the quadruple aim of care: improving health outcomes and lowering the cost of care, while also improving the patient and care provider experience.

More information on Philips’ enterprise telehealth solutions portfolio can be accessed .

The Gartner Market Guide on Virtual Care can be accessed .

[1] Gartner, “Market Guide for Virtual Care Solutions”, Sharon Hakkennes, Pooja Singh, 26 October 2020.

Gartner Disclaimer: Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

For further information, please contact:

Anna Hogrebe

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



 

Attachment

EN
05/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: RDOS. 4T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADELL...

Rdos. 4T’25 vs 4T’24: Ventas: 5.097 M euros (+1,1% vs -0,9% BS(e) y -1,0% consenso); EBITA Aj.: 770 M euros (+13,4% vs +0,6% BS(e) y -1,0% consenso); BDI: 397 M euros (-333 M euros en 2024 vs 275 M euros BS(e) y 276 M euros consenso); Rdos. 2025 vs 2024: Ventas: 17.834 M euros (-1,0% vs -1,6% BS(e) y -1,6% consenso); EBITA Aj.: 2.195 M euros (+5,7% vs +1,5% BS(e) y +1,0% consenso); BDI: 897 M euros (-698 M euros en 2024 vs 775 M euros BS(e) y 776 M euros consenso).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch